Dr Mathieu Sarracanie is a Senior Lecturer in the School of Medicine, Medical Sciences and Nutrition at the University of Aberdeen. As an MR physicist, his research focuses on methodological developments for low-field MRI, including fast-imaging techniques, multi-parametric imaging, and instrumentation for RF detection such as custom low-frequency RF detectors and preamplifiers. He was trained as a biomedical engineer at Université Toulouse III - Paul Sabatier and Université de Technologie de Compiègne in France before completing a Ph.D. in Physics in 2011 at Université Paris-Sud, France. He then worked as a post-doctoral researcher at Harvard University in the Department of Physics and at the MGH/HST Athinoula A. Martinos Center for Biomedical Imaging from 2011 to 2016, where he developed fast Overhauser-enhanced MRI and ultra-low magnetic field imaging techniques.
In 2014, he co-founded Hyperfine, a company that launched the first FDA-cleared portable MRI for point-of-care neuroimaging. In 2017, he co-founded the Center for Adaptable MRI Technology (AMT Center) at the University of Basel in Switzerland together with Dr Najat Salameh. The center relocated to the University of Aberdeen Institute of Medical Sciences in April 2023. He serves as a member of the International Society for Magnetic Resonance in Medicine (ISMRM) Annual Meeting Program Committee (2022-2024) and as vice-chair of the ISMRM Study Group on Low-field MRI. His key publications include work on low-field MRI systems and techniques appearing in journals such as Scientific Reports, Science Advances, and NMR in Biomedicine.